Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 known ✓ | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34512 | 0.98 | ALDH1A1 (0.35) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| Iodide SCHEMBL28719252 | 0.95 | ALDH1A1 (0.34) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| Bromide SCHEMBL30353850 | 0.95 | ALDH1A1 (0.34) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| Bromide SCHEMBL6890023 | 0.93 | ALDH1A1 (0.33) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL31364278 | 0.89 | ALDH1A1 (0.32) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| Bicarbonate SCHEMBL26607952 | 0.87 | KDM4E (0.41) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL28766410 | 0.86 | ALDH1A1 (0.30) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL17532969 | 0.85 | HRH3 (0.32) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL25934333 | 0.84 | RAPGEF4 (0.37) | RAPGEF4HRH3 | |
| SCHEMBL18538762 | 0.82 | NPSR1 (0.40) | ALDH1A1POLBMAPTHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 606 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192258-A | Synthesis method of 3-substituted N-aryl pyrrolidine | 兰州大学 | 2025-06-24 | — | — | CN | claimed |
| CN-120040485-A | Single-molecule difunctional organic catalyst for ring-opening copolymerization of epoxide and cyclic anhydride as well as preparation method and application thereof | 浙江大学 | 2025-05-27 | — | — | CN | claimed |
| US-20250096271-A1 | ELECTRODE BINDER COMPRISING CATIONIC SEMI-IPN POLYMER, ELECTRODE AND CELL COMPRISING THE SAME | UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (KR) | 2025-03-20 | — | — | US | claimed |
| CN-119462581-A | Preparation method of 3-bromo-7-chlorodibenzo [ b, d ] furan | 中钢天源股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119002179-A | Photosensitive resin composition, dry film resist, photosensitive laminate, resist pattern, and semiconductor package carrier | 杭州福斯特电子材料有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118727075-A | Electroplating solution and electroplating process for filling TSV blind holes with high depth-to-width ratio | 厦门大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118307410-A | Preparation method of chiral secondary alcohol compound | 武汉大学 | 2024-07-09 | — | — | CN | claimed |
| CN-114533593-B | Cosmetic in the form of a liquid paste at normal temperature and composition of biodegradable copolymers | 莹特丽股份公司 | 2024-06-25 | — | — | CN | claimed |
| CN-114478656-B | Method for synthesizing oligonucleotide-aromatic carboxylic acid by aldehyde group oxidation | 康龙化成(宁波)科技发展有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-114315874-B | Method for preparing tetra-substituted alkenyl borate derivative | 中国科学院大连化学物理研究所 | 2023-08-18 | — | — | CN | claimed |
| EP-1836233-A1 | HALOGENATED THIOPHENE MONOMER FOR THE PREPARATION OF REGIOREGULAR POLYTHIOPHENES | Honeywell International Inc. (US) | 2007-09-26 | — | — | EP | claimed |
| EP-1836184-A1 | IMPROVED PROCESS FOR THE KUMADA COUPLING REACTION | Honeywell International Inc. (US) | 2007-09-26 | — | — | EP | claimed |
| US-7262264-B2 | Halogenated thiophene monomer for the preparation of regioregular polythiophenes | HONEYWELL INTERNATIONAL INC. (US) | 2007-08-28 | — | — | US | claimed |
| US-7205414-B2 | Process for the Kumada coupling reaction | HONEYWELL INTERNATIONAL INC. (US) | 2007-04-17 | — | — | US | claimed |
| US-7122559-B2 | Phenylglycine derivatives useful as serine protease inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-10-17 | — | — | US | claimed |
| WO-2006076150-A1 | IMPROVED PROCESS FOR THE KUMADA COUPLING REACTION | HONEYWELL INTERNATIONAL INC. (US) | 2006-07-20 | — | — | WO | claimed |
| WO-2006076156-A1 | HALOGENATED THIOPHENE MONOMER FOR THE PREPARATION OF REGIOREGULAR POLYTHIOPHENES | HONEYWELL INTERNATIONAL INC. (US) | 2006-07-20 | — | — | WO | claimed |
| US-20060155105-A1 | Halogenated thiophene monomer for the preparation of regioregular polythiophenes | HONEYWELL INTERNATIONAL INC. | 2006-07-13 | — | — | US | claimed |
| US-20060155134-A1 | Process for the kumada coupling reaction | HONEYWELL INTERNATIONAL INC. | 2006-07-13 | — | — | US | claimed |
| US-20040204412-A1 | Phenylglycine derivatives useful as serine protease inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204412-A1 | Phenylglycine derivatives useful as serine protease inhibitors | F7, SERPINE1, HABP2 | HRH3 606/4885ALDH1A1 3767/4885POLB 3339/4885 |
| US-20060155134-A1 | Process for the kumada coupling reaction | KMT5A, KMT5C, KCNT1 | HRH3 2778/4885ALDH1A1 698/4885POLB 1884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.